A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients

A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individuals, as these agents are not effective in patients harboring CXCR4 (X4) coreceptor-using viral variants. We developed a clinical laboratory-based genotypic tropism test for detection of CCR5-using (R5...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagan, Ron M., Johnson, Erik P., Siaw, Martin, Biswas, Pinaki, Chapman, Douglass S., Su, Zhaohui, Platt, Jamie L., Pesano, Rick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459909/
https://www.ncbi.nlm.nih.gov/pubmed/23029482
http://dx.doi.org/10.1371/journal.pone.0046334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459909/
https://www.ncbi.nlm.nih.gov/pubmed/23029482
http://dx.doi.org/10.1371/journal.pone.0046334

Ejemplares similares